Condition
Ovarian Cancer (OvCa) clinical trials and research
Research outlook What's coming for Ovarian cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 5 Ovarian Cancer (OvCa) clinical trials that are recruiting, at sites in 4 countries (most in China (2), United States (1), South Korea (1)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Ovarian Cancer (OvCa) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Rectosigmoid Lesion Excision vs. Resection in Advanced Ovarian Cancer | — | Hangzhou, Zhejiang | Recruiting | Jun 1, 2026 |
| Trastuzumab deruxtecan versus standard treatment for ovarian cancer that returned after PARP inhibitor therapy | Phase 2 | Seoul, Seoul | Recruiting | Jan 14, 2026 |
| Analysis of the ovarian (infundibulopelvic) ligament removed during ovarian cancer surgery | — | Las Palmas de Gran Canaria | Recruiting | Aug 3, 2025 |
| Comprehensive pre-surgery conditioning, with or without planned preoperative cancer therapy, before major abdominal or pelvic cancer operations. | Phase 2 | Houston, Texas | Recruiting | Jul 3, 2025 |
| Assessing urinary proteins to differentiate ovarian cancer from non-cancer conditions | — | Changsha, Hunan | Recruiting | Jan 7, 2025 |
All recruiting trials (5)
-
Rectosigmoid Lesion Excision vs. Resection in Advanced Ovarian Cancer
This study tests whether removing a rectosigmoid lesion without full bowel resection can be as safe as removing the bowel segment in women with advanced ovarian cancer.
-
Trastuzumab deruxtecan versus standard treatment for ovarian cancer that returned after PARP inhibitor therapy
This study will test whether trastuzumab deruxtecan helps people with HER2-expressing recurrent ovarian, fallopian tube, or peritoneal cancer that progressed on prior PARP inhibitor therapy compared with standard chemotherapy or bevacizumab.
-
Analysis of the ovarian (infundibulopelvic) ligament removed during ovarian cancer surgery
This project will test whether cancer in the infundibulopelvic ligament removed at surgery is linked to para‑aortic lymph node spread and outcomes in people with epithelial ovarian cancer.
-
Comprehensive pre-surgery conditioning, with or without planned preoperative cancer therapy, before major abdominal or pelvic cancer operations.
This trial will test whether a comprehensive prehabilitation program, given alone or with planned neoadjuvant therapy, helps pre-frail or frail adults with pancreatic, ovarian, kidney, or bladder cancer better tolerate major cancer surgery.
-
Assessing urinary proteins to differentiate ovarian cancer from non-cancer conditions
This study is testing if certain proteins in urine can help tell the difference between women with ovarian cancer and those without it.
Related topics
Quick answers
How many Ovarian Cancer (OvCa) clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (2 trials), United States (1 trial), South Korea (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.